Business
Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation Diagnostics and Blood Technology
RA'ANANA, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira,” “Inspira Technologies,” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced a strategic expansion of its core blood laboratory capabilities, marking a substantial step in the Company’s evolution into a broader cutting edge technologies, positioning it for accelerated future growth. The strategic expansion includes transitioning to a
About this update from Qtrex Quantum Ltd.
[{"type":"image","alt":"Inspira Technologies","displaySize":"","headline":null,"caption":"Inspira Technologies","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":71,"url":"https://media.zenfs.com/en/globenewswire.com/f3cd7fe01a01b6d2fcb4b07615d7a878"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_Fe6OoV8FaU0yBPMg3F6WQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTk5O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/f3cd7fe01a01b6d2fcb4b07615d7a878","width":300,"height":71}},"lazy":false},{"type":"text","content":"RA'ANANA, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira,” “Inspira Technologies,” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced a strategic expansion of its core blood laboratory capabilities, marking a substantial step in the Company’s evolution into a broader cutting edge technologies, positioning it for accelerated future growth.","length":452,"tagName":"p"},{"type":"text","content":"The strategic expansion includes transitioning to a substantially larger, state-of-the-art laboratory facility, while planning to increase recruitment of specialized personnel, upgrading advanced research instrumentation, and expanding its operational capacity. The upgraded laboratory, expected to become fully operational within the coming weeks, is designed to support Inspira’s long term strategy to broaden its technological focus across blood-based clinical diagnostics and next-generation blood-analysis technologies.","length":524,"tagName":"p"},{"type":"text","content":"The enhanced facility is expected to enable a significant increase in sample processing capacity and provide the critical infrastructure needed to integrate advanced capabilities throughout the laboratory. Inspira is also planning to strengthen its professional team by adding engineers and data-science experts to expand the Company’s analytical and operational capabilities. ","length":377,"tagName":"p"},{"type":"text","content":"This strategic upgrade is focused on providing the foundation required to accelerate Inspira’s commitment to innovation, positioning the Company for the next phase of growth, targeting high value underserved medical needs.","length":222,"tagName":"p"},{"type":"text","content":"Daniella Yeheskely-Hayon, CTO of Inspira ...